What signal is this?
On 9 November MFDS issued a release titled "Joint public-private mission dispatched to expand K-beauty exports to Latin America". According to industry reporting on it, the mission runs 24-26 February 2027 in Sao Paulo, Brazil, with about 20 participating companies. Applications are taken on the Korea Cosmetic Association website until 23 November, and selections are announced on the 24th. The Korea Cosmetic Association, the KOTRA Sao Paulo office and the Korea International Trade Association's Sao Paulo office run it jointly.
The three days are built from three different kinds of activity. Day one is a pop-up store facing local consumers plus buyer business meetings; day two a head-of-agency bilateral between MFDS and Brazil's health surveillance agency ANVISA; the final day a joint regulator-industry session with ANVISA staff attending. Consumer response, distribution talks and regulatory questions all sit inside a single trip.
Behind it are both numbers and a diplomatic calendar. Reporting puts Korean cosmetic exports to Brazil at USD 9 million in 2022 rising to USD 54 million in 2025, a sixfold increase in three years, and describes Brazil as the world's third largest cosmetics market as of 2025. The foundation for this dispatch is a memorandum of understanding on regulatory cooperation for health-related products, including cosmetics, signed by MFDS and ANVISA following the Korea-Brazil summit in February 2026.
Until now K-beauty exports have been heavily concentrated in North America, Southeast Asia and Japan. Latin America is being named as a new axis not only because of market size but because a regulatory channel now exists. A head-of-agency meeting and a joint industry session in the same week means a forum opens where an individual brand can formally raise questions it normally cannot get to.
Three limits apply when reading this signal. First, the export figure depends on how it is counted: the same outlet's analysis of 2025 full-year export results puts Brazil at USD 60 million, up 115.1% year on year, which differs from the USD 54 million figure. Second, the sixfold increase starts from a small base of USD 9 million in 2022, so it should not be read as proof the market is already open. Third, the dispatch is a year away, so the programme and dates may change, and the development judgements below are our reading of the reported conditions, not a guarantee of any ANVISA review outcome.
1. The application deadline arrives before the development schedule
Lay the dates out backwards and the structure shows. Applications close on 23 November and selections land on the 24th, while the dispatch itself is in February 2027. There are roughly 15 months between application and travel, but only two weeks to decide whether to apply at all. What is needed now is therefore not a finished product but an answer to which product you will take, under which market conditions.
That gap is an opportunity rather than a problem. Fifteen months is enough to walk through formulation, stability testing, container ordering and local approval preparation in sequence. Leave the period idle and you arrive with nothing but samples. Given that the pop-up store and buyer meetings are placed on day one, deciding now what items go in front of those audiences is the stronger position.
The thing worth settling at application stage is item scope. A plan to take the whole range multiplies labelling and approval work by the number of SKUs. Narrow it to one or two hero items plus the items that support them and 15 months becomes enough to align approval and production schedules together.
The second is ownership. To raise a question at the regulatory session, someone has to write the question. If formulation, labelling and export sit with different companies, decide at application time who is responsible for gathering local regulatory requirements, or the forum a year from now goes unused.
Finally, confirm the eligibility terms from the organiser's own notice. What reporting covers is scale, period and programme; participation criteria, cost sharing and required documents are in the Korea Cosmetic Association notice itself. The first job inside the two weeks is reading that notice in full and checking whether your company qualifies.
- Whether applications (23 Nov), selection (24 Nov) and dispatch (24-26 Feb 2027) are written on one line
- Whether the items to take were narrowed to one or two hero products
- Whether someone owns the gathering of local regulatory requirements
- Whether eligibility, cost and required documents were checked in the organiser's notice
2. Grade 2 pre-approval asks about product specification first
The variable every report points to is approval. In Brazil, functional cosmetics such as sunscreen and whitening creams are mostly classified as grade 2 high-risk and must go through pre-market approval. Requiring pre-approval means the review period sits inside your launch schedule, and what gets reviewed is ultimately the formula and the label content.
So the first fork in product planning becomes which grade you design the product into. Within the same concept, classification can change depending on whether you declare an SPF figure or claim whitening. Entering the market first with a product built around moisturisation and skin texture, and attaching functional items later, is one way to keep the first launch date out of the review period.
Conversely, if you decide to go functional, that decision has to be locked at the formulation stage. A product going through pre-approval is hard to amend after filing. It is safer to plan development on the premise that the UV filter composition, concentration, format and container material are all fixed at once.
The ingredient list also has to be reviewed against the destination market. What can be used in Korea and what can be used in Brazil are not necessarily the same, and UV filters, colourants and preservative systems are exactly the areas where permitted lists differ by market. Sending the domestic formula as is and adjusting later means spending the review period twice.
One distinction matters here. Grade 2 classification and pre-approval are conditions confirmed by reporting, but the grade and the dossier required differ product by product. That is why the mission's regulatory session is useful. "What grade is our product" has no general answer; it is a question to put to the agency directly.
- Whether general cosmetic or functional was decided at planning stage
- Whether a functional route is planned to fix formula, concentration, format and container at once
- Whether UV filters, colourants and the preservative system were checked against Brazil's permitted lists
- Whether the grade question was written down as something to ask at the session
3. Labelling and the local representative come before the packaging order
The other burdens reporting names are Portuguese labelling and the appointment of a local legal representative. Both look like steps you attach after the product is finished, but in practice both have to precede container and packaging orders.
Labelling comes first because of area. Portuguese text often runs longer than Korean or English, and the ingredient list, directions, warnings and manufacturing or import details all have to fit. Fix container size and label area first and the required text does not fit, forcing a volume change or an extra outer pack. The smaller the item, the earlier this breaks.
The local representative comes first because of whose name goes on the documents. Approval and import paperwork carries the local entity or representative details, so until the representative is appointed the information to print on the label is not settled either. Appointing one means agreeing a contract and a scope of responsibility, which takes time, and with a February 2027 dispatch it is an item that has to be closed before then.
A practical approach is to design the label in two layers. Fix the elements common to every market (brand, product name, volume, core visual) and separate the market-specific elements (local-language text, responsible-party details, regulatory statements) into a replaceable area. Markets added later then do not require reworking the container tooling.
Advertising copy has to be reviewed alongside the label. What is permitted in Korea and what is permitted in Brazil differ, and functional claims connect directly to grade classification. Fixing marketing copy first and looking at regulation later comes back as the cost of reprinting packaging.
- Whether the label area needed for Portuguese text was calculated before fixing the container
- Whether appointing a local legal representative is scheduled as a pre-dispatch task
- Whether the label separates a common area from a market-specific replaceable area
- Whether advertising copy was reviewed together with grade classification and locally permitted wording
4. A pop-up store asks for shipping conditions, not samples
The day-one pop-up store facing local consumers is a different thing from a trade booth. If consumers actually handle and react to the product, finished-goods form is needed, and sending finished goods into the country touches customs and labelling conditions by itself.
That creates items to confirm with the organiser at application stage: whether pop-up stock is treated as for sale or as display and trial, whether the organiser handles shipping and customs collectively, and how far product can travel without local-language text. The answers change both the quantity and the label state you have to prepare.
Quantity planning follows. Small trial sizes for consumers, full-size units for buyer meetings and retained samples for dossiers and records serve different purposes and have to be counted separately. From a production standpoint these three strands need to sit inside one production run for the cost to work. COSLAB consults on projects from 1,000 units upward, and what is actually feasible depends on the formula, container, raw materials, process and specification.
Shipping conditions also bear on format choice. Long-haul air or sea freight plus the local climate lengthens heat exposure, which raises emulsion stability, fragrance drift and container sealing as test items. Setting accelerated stability conditions on the premise of the Brazil route in advance avoids rushed testing just before departure.
Last, decide now how local reactions will be recorded. The pop-up is a one-off event, but the questions it produces (fragrance strength, texture, volume, price point) are grounds for changing the next run's formula and specification. Bring a recording format and the trip leaves development inputs behind rather than impressions.
- Whether the pop-up stock's status (sale, display, trial) and the customs handler were confirmed with the organiser
- Whether trial, buyer and retained quantities were counted separately and placed in one run
- Whether stability test conditions assume the Brazil route and climate
- Whether a recording format exists to turn local reactions into formula and specification inputs
5. Shorter review times are still only an agenda item
At the day-two head-of-agency bilateral, MFDS is reported as planning to discuss practical approval simplification, including shorter review periods. For a brand this is the most awaited item, but its current status is a plan to discuss. It is an agenda item, not an outcome.
Schedules therefore have to be built on today's requirement. Assume simplification lands and pull the launch date forward, and if the rules stay as they are, production and marketing slip together. Treat simplification as something that creates slack if it happens, and set the baseline at the present condition of required pre-approval.
The real benefit of regulatory cooperation lies elsewhere. With a memorandum and a standing consultation channel, there is a route for specific enquiries and a better chance of hearing about rule changes early. What gets shortened may be less the review period than the time it takes to learn what you need to prepare.
That is why writing down the questions to take is important. Questions like "what dossier does our product category need", "which test reports are accepted" and "how far can domestic test data be used" determine the quality of the answers far more than a request to simplify the process.
And we would not tie the whole schedule to Brazil alone. If Latin America is at the stage of opening as a new axis, design the first item to a specification usable in both your existing core markets and Brazil, and split off a Brazil-specific specification only after demand is confirmed. That order lowers inventory risk.
- Whether the launch schedule is built on today's pre-approval requirement
- Whether any schedule assuming simplification has crept into the plan
- Whether session questions were written at the level of dossiers and test reports
- Whether the first item's specification is shared with existing core markets
The first question for the brief
Try turning the line that reads "enter Brazil" into two. The first is items: which products, how many SKUs, designed as general cosmetics or as functional ones. The second is the conditions that decision drags along: grade 2 pre-approval, Portuguese label area, the local representative and the stability test scope implied by shipping. All of it is decided on the first line.
Next write the dates. Put down applications 23 November, selection 24 November and dispatch 24-26 February 2027, then fill in backwards the formula freeze, container order, approval filing and production start between them. Fifteen months looks generous, but once the pre-approval review period is inside it, the development time you can actually use is shorter.
The last line is a question list. Unless you write now what you will ask at the regulatory session and the buyer meetings, the trip ends as a study tour. The most useful single line to add to the brief today is who you will ask about your product's grade and required dossier, and in what words.
Sources
- K-뷰티 중남미 수출 확대 위해 민·관 합동 진출지원단 파견 — 식품의약품안전처, 2026-11-09
- 식약처, K-뷰티 남미(브라질) 공략 전면 지원 나선다 — 코스모닝, 2026-11-09
- 식약처, 브라질 화장품 지원단 민관 합동 파견…까다로운 현지 인허가가 변수 — 바이오타임즈
For more context, see the product development guide and MOQ 1,000 guide.